Objective: To investigate whether maternal migraine was associated with preterm birth.
Introduction
Most persons with migraine are women of childbearing age. In childhood, the prevalence of migraine is comparable in boys and in girls, but near the age of puberty the frequency of migraine increases in females so that in 1 and after 2 the second decade of life a majority of migraineurs are women. Other indications that factors relevant to reproductive function interact with propensity to migraine are the concentration in some women of migraine headaches at the time of menstrual periods and the commonly observed decline of migraine attacks during pregnancy or after menopause. 3 Ischemic stroke is more common in women with than without migraine, 4, 5 and risk is increased in those taking oral contraceptives. 6 There is a striking increase in frequency of pregnancy-associated stroke in women with a history of migraine, although the absolute level of that risk is low. 7 Migraine is associated with pre-eclampsia, [8] [9] [10] [11] itself a marker of risk for later ischemic stroke 12 Other disorders influenced by migraine history include endometriosis and metrorrhagia. 13 Despite these observations linking endocrine and reproductive function as well as vascular disorders with migraine, and the high prevalence of migraine in women of reproductive age, there has been relatively little attention given to whether maternal migraine or its treatment influence pregnancy outcomes. We report observations indicating that in a case-control study within a population-based study in Western Australia, a history of maternal migraine self-identified in the first half of pregnancy was associated with heightened risk of preterm birth.
Methods
This case-control study of cerebral palsy (CP) and perinatal death was designed to investigate factors associated with risk of CP. CP was defined as a disorder of movement and/or posture and of motor function due to a non-progressive interference/lesion or abnormality of the developing immature brain. Including all births in Western Australia between 1980 and 1995 (N ¼ 380 918), perinatal and vital outcome data are available in a database linking birth and death registries with pregnancy and delivery information collected by the attending midwife, and including >99.5% of registered births. In Western Australia, each birth is attended by a midwife, regardless of whether an obstetrician is in attendance. This midwife is responsible for completing the statutory 'notification of birth attended' form that is filed with the Western Australian Department of Health. The data requested on this form include hospital of delivery, gestational duration, date, and plurality of birth and pregnancy complications. However, this means of data collection is not optimal for pregnancy complications because the midwife may not have cared for the parturient throughout pregnancy or otherwise be intimately familiar with her history. For this reason, for three groups selected from the same population, the CP and perinatal death collected more detailed perinatal data directly from medical records. These groups were: (1) all children with CP born between 1 January 1980 and 31 December 1995, whose CP was not acquired post neonatally and whose functional motor impairment was evident in activities of daily living, as identified by the Western Australian Cerebral Palsy Register; (2) neonatal survivors without CP, individually matched to each CP case for date of birth (within 12 months), gestational age (GA) at delivery (within 1 week), and plurality of birth. (3) A representative sample of intrapartum stillbirths or neonatal deaths delivered during study years and not the result of medical termination of pregnancy or lethal birth defects.
For each study pregnancy, the hospital of birth was identified and medical records sought from the hospitals of delivery and any additional transferring or receiving hospitals, general practitioners or obstetricians identified in the medical record as involved. Data were collected by reviewers blind to case status. All data of possible relevance to estimation of gestational duration was extracted from the medical record (date of last normal menstrual period, certainty of this date, date and conclusions of any fetometric ultrasound scans, dates of clinical assessments of gestational duration and neonatal estimate of gestational duration). The best estimate of gestational duration was chosen according to our published algorithm. 14 For this report pre-eclampsia was considered a dichotomous variable. Gestational hypertension was considered present if blood pressure X140/X90 or systolic blood pressure rise of 20 mm or diastolic blood pressure rise of 15 mm, proteinuria was considered present if recorded in the medical record.
Information on presence or absence of a history of migraine was drawn from the questionnaire at presentation for antenatal care, usually in the first trimester, in which women were questioned by a medical attendant about a series of chronic conditions. There was no further investigation of the migraine diagnosis by record review, and no query as to recency, severity, headache subtype or treatment.
The study was approved by the Princess Margaret Hospital/King Edward Memorial Hospital Ethics Committee, the Confidentiality of Health Information Committee of the Western Australia Department of Health, and by individual hospital and regional ethics committees, whose documents can be provided on request.
Statistics
Within each case status group (no-CP, CP and perinatal death), the frequency of preterm birth to women reporting migraine was compared with the frequency in women reporting no migraine from which comparison were calculated odds ratios (OR) and 95% confidence limits for preterm births associated with maternal migraine. Similarly within case groups, the frequency of primiparity, maternal smoking, pre-eclampsia and distributions of maternal age, and proportion of optimal birth weight were compared by migraine status. For those born preterm, the antecedent of their birth was classified as spontaneous onset of preterm labor, as preterm pre-labor rupture of membranes, or as delivery preterm on medical indication (by induction or section before onset of labor). The distributions of these factors were compared between case status groups. Within the CP group, the distribution of clinical CP subtypes was compared between infants born to women with and those without migraine. The relative contributions of maternal migraine and pre-eclampsia to risk of preterm birth were assessed with multivariable logistic regression by case status group.
Results
In this study there were 2267 births, of which 741 were of infants later described as having CP, 738 were infants without later CP (no-CP) individually matched to an infant with CP for gestational age (GA) (within 1 week), multiplicity, and year of birth, and 605 were a representative sample of perinatal deaths (intrapartum stillbirths and neonatal deaths) during the same years. Information on maternal migraine history was missing for 9.2% of study subjects.
Of women whose migraine history was known, 3.3% of mothers of no-CP children (22/660) reported a history of migraine, as did 3.9% (25/637) of children with CP and 4.2% (25/596) of infants who died in the perinatal period.
Migraine and gestation at delivery
In the no-CP group, there was an association of history of maternal migraine with birth before 37 weeks GA: 1.8% of mothers of term born no-CP children had migraine, as compared with 6.2% of preterm born no-CP children (OR ¼ 3.5, 95% confidence interval (CI) 1.5, 8.5; Table 1 ). There was no trend toward increasing prevalence of migraine with decreasing GA within the preterm stratum. The GA distribution of non-CP children with unknown migraine status was very close to that of non-CP children without maternal migraine, suggesting that few of those with missing data had mothers with migraine.
There was no difference in the prevalence of maternal migraine in children with CP born term versus preterm. For perinatal deaths, however, we observed that preterm infants more often than term born infants had mothers with a history of migraine (OR ¼ 7.3, 95% CI 0.98, 54; Table 1 ).
Preterm birth was most often initiated by spontaneous labor or premature rupture of membranes, both in women with and without migraine, and proportions with delivery for medical indication were little different in these two groups. There was no apparent excess of iatrogenic delivery for poor fetal growth in offspring of women with migraine.
Comparing the antecedents of preterm birth in the no-CP group suggested that migraine exerted its effect on preterm birth through spontaneous preterm labor rather than through pre-eclampsia, but in both CP and perinatal death groups born preterm, migraineurs were less likely to experience spontaneous onset of preterm labor as compared with births to women reporting no migraine.
Migraine and intrauterine growth
More women with migraine gave birth to a no-CP infant weighing <2500 g than did women without migraine (54.5 versus 29.5%, P ¼ 0.012). There was an excess of poorly grown births to mothers of no-CP children with migraine, which attained statistical significance when poor growth was defined by a dichotomous description of infants as small for GA (OR ¼ 3.8, P ¼ 0.036) but not when defined as >2 s.d. below optimal birth weight for gestation, gender, maternal parity and height (OR ¼ 2.5, P ¼ 0.076). 15 Although children with CP were more likely to be suboptimally grown than no-CP children (OR ¼ 2.26 (P<0.0001) defined as small for gestational age, OR ¼ 2.27 (P<0.0001) if defined as <À2 s.d. below optimal), for them association between poor growth and migraine was less marked (OR ¼ 1.8 (P ¼ 0.24) for small for gestational age and OR ¼ 1.5 (P ¼ 0.37) for <À2 s.d. below optimal).
Migraine and maternal characteristics
Women with migraine were slightly and not significantly older than women who did not report migraine. The proportion of women who were primiparous did not differ significantly between those with and without migraine in any of the three groups. Migraine was associated with non-smoking in women giving birth to a control child: 5.3% (1/10) and 29.4% (138/470) of women smoked in those with and without migraine respectively, OR ¼ 0.13 (P ¼ 0.013): but not in those giving birth to a CP child or a perinatal death where the smoking rates were similar in women with and without migraine. The statistics for those giving birth to CP children were 27.3% (6/22) and 34.5% (158/458) smokers for those with and without migraine, and for those giving birth to a perinatal death were 36.4% (8/22) and 32.3% (156/483) for those with and without migraine. The association between outcome and proportion of smokers in those with migraine was most marked in those giving birth preterm.
Migraine and birth outcome
Maternal migraine was twice as frequent in term born children with CP (3.9%) as compared with those without CP (1.8%), but this difference did not reach statistical significance (OR ¼ 2.18, 95% CI 0.92, 5.15).
Among children born preterm, maternal migraine was observed less frequently in those with CP (again 3.9%) than in the no-CP group (6.2%): OR ¼ 0.62 (P ¼ 0.27). Preterm infants with CP whose mothers had migraine were three times as likely to be described to have a right hemiplegia, (5/9 (56%) versus 35/220 (16%), P ¼ 0.01) and only half as likely to have spastic diplegia in our study (2/9 (22%) versus 111/220 (50%), P ¼ 0.09) as compared with preterm born infants not exposed to maternal migraine. The same was not true for left hemiplegia. In term born infants, there was no excess of hemiplegia following maternal migraine.
Most of the children in this study were born before 1992. None of the women was known to have received triptan medication. Other information on medication was insufficient for analysis.
Migraine and pre-eclampsia Among mothers of children with CP or perinatal death, but not in the no-CP group, more women with migraine self-identified early in pregnancy developed pre-eclampsia with proteinuria (Table 2) . It, thus, appeared that more women who had both migraine and pre-eclampsia had infants who died or survived with CP.
In logistic regression analyses in the no-CP group, both maternal migraine (OR ¼ 3.1, 95% CI 1.2 to 7.8) and preeclampsia (OR ¼ 1.9, 95% CI 1.12 to 3.9) predicted preterm birth in a model that included the combination, giving a best estimate that pre-eclampsia is responsible for about 20% of preterm births to women with migraine.
Comments
We observed an association of maternal migraine with preterm birth in survivors without CP and in infants who died in the perinatal period. A similar association was not observed in children with CP, in whom different pathways to preterm birth may predominate.
Migraine and preterm birth
The previous literature contains suggestions, but not robust evidence, of a link between maternal migraine and preterm birth. In a prospective cohort study from three clinical units, designed to examine the association of migraine with hypertensive disorders of pregnancy, Faccinetti et al. 9 reported as secondary outcomes that birth before 37 weeks and birth weight below 2500 g were non-significantly more frequent in the infants born to 270 women with migraine as compared with 432 women without migraine. The ORs (1.64 (0.85 to 3.16) and 1.97 (0.98, 3.98)) were further lowered by adjustment for age, family history of hypertension and smoking. In a population-based study of women with severe migraine during pregnancy, mean GA and birth weight were similar in infants of mothers with and without migraine, 7 but in a recent report mean GAs and birth weights were lower in offspring of women with migraine. 11 Three registries of women who used triptan drugs for migraine in pregnancy had somewhat elevated rates of preterm deliveries, not further analysed; [16] [17] [18] the role of drug exposure as compared with disease severity was not explored. Thus current evidence for an association of migraine with preterm birth is suggestive but ambiguous.
If maternal migraine and preterm birth are associated, why are they? Epidemiological evidence suggests that there are two general categories of explanation for severe prematurity that may relate to less severe prematurity as well: inflammation as indicated by histological chorioamnionitis and recovery of placental microorganisms, and disordered placentation indicated by pre-eclampsia or intrauterine growth restriction. 19 There is evidence that migraine is associated with markers of inflammation, such as elevated C-reactive protein and of homocysteine, 20 (although that evidence is not unambiguous 21 ) and in children with elevated levels of certain cytokines, 22 and with disorders such as asthma that have an inflammatory component. 1 Migraine and pre-eclampsia Since 1959, reports have associated migraine with approximately a doubling of risk of pre-eclampsia. 23, 11 The Sanchez study used standardized criteria, as most previous studies had not, and in that study the association of migraine with pre-eclampsia was attenuated and no longer significant after adjustment for maternal age, parity and pre-pregnancy adiposity. 10 In the Western Australian experience described in this report, maternal migraine was associated with a higher rate of pre-eclampsia in infants with CP and in perinatal deaths, but not in infants surviving without CP. Data in this study suggest that about 20% of preterm birth was mediated by the association with pre-eclampsia. Pre-eclampsia is itself associated with pre-term birth, perinatal death 3 and with infant stroke in the perinatal period, 24 and also with risk of maternal pregnancy-associated stroke 7 and with long-term stroke risk in the mother. 4 In preeclampsia, 25, 26 as in migraine, 27, 28 there are features of endothelial dysfunction, platelet activation and inflammation.
Migraine and smoking
Smoking is somewhat protective against preeclampsia 29 but positively related to risk of migraine. 30 Few women with migraine who gave birth to controls in this Western Australian study smoked, but the proportion of smokers among migraineurs was not reduced in the poor outcome groups.
Maternal migraine and CP
We observed an apparent doubling of risk of CP in term infants born to women with migraine, not statistically significant in these numbers. Maternal migraine has not been examined as a risk factor for CP in any previous study we know of. Because the no-CP group were matched with children with CP for GA at delivery, and the association of maternal migraine with CP might operate at least in part via its association with preterm birth, the overall association of migraine and CP cannot be measured in this study and is likely to be underestimated in term infants. Our observation of an excess of right hemiparesis among preterm children with CP born to women with migraine suggests the important possibility that maternal migraine may be associated with increased risk of perinatal stroke, a common cause of hemiparetic CP. In perinatal stroke, right hemiparesis occurs more frequently than left hemiparesis, perhaps related to the flow path for emboli from placenta to brain via the patent foramen ovale in the fetus/neonate. Thus the excess of right hemiparesis observed in this study is compatible with perinatal stroke. Migraine is an important risk factor for pregnancy-associated ischemic stroke in the mothers, 7 and a risk factor for post-menopausal ischemic stroke. It is a testable but as yet untested hypothesis that maternal migraine, or factors associated with it, is related to risk of stroke in the fetus/infant.
Complex web of interactions
In discussing migraine and pre-eclampsia, Wallis and Saftlas 31 stress that migraine and preeclampsia share a number of features, including associations with obesity, platelet activation, hyper-coagulation, inflammation, infertility, smoking history (in opposite directions), stroke and cardiovascular disease, that must be taken into account in efforts to make sense of the observed relationships. That complexity is not less for migraine and preterm birth.
Among findings of potential interest is, in a population-based national registry of newborns without congenital malformations, a threefold greater rate of thyroid disease in women with than without migraine. 8 Maternal thyroid disorder is, in turn, associated with risk of preterm delivery 31 and with risk of neonatal encephalopathy, 32, 33 a major precursor of CP in term infants. 34 A recent study links pre-eclampsia with thyroid hypofunction. 35 Factors unmeasured in this study may be relevant to the associations observed.
Limitations and strengths of this study It is a serious limitation of this report that none of the three groups examined (no-CP, CP and perinatal death) had a GA distribution representative of the total population. That is because, this study was designed to examine the risk factors for CP, the no-CP group was matched for GA with CP cases, and both CP and perinatal death are more frequent among infants born before term. However, it is not obvious a priori that there is a bias related to migraine in GA distribution of births, and the few previous studies to investigate outcome of pregnancy in woman with migraine did not consistently find more preterm labor or low birth weights. 8, 36, 37 Other important limitations are the low observed prevalence of migraine (perhaps suggesting it is active or severe migraine that is reported), the lack of medical documentation and classification, and lack of information on migraine subtype, severity, frequency or recency; and no information on medications use or on whether there was associated placental pathology. We report the observations in the hope that these shortcomings will be rectified in a future study designed to investigate this association. Such a future study might also address whether maternal migraine is a risk factor for CP, and more specifically for perinatal stroke resulting in hemiparetic CP. What are the roles of migraine and its subtypes, its treatment, and the associated obesity, smoking and thyroid disease and their interactions, as potentially modifiable risk factors for preterm birth and for cardiovascular and cerebrovascular disease?
Conclusion
We report that maternal migraine as self-identified early in pregnancy, or factors associated with migraine, was apparently linked with increased risk of preterm birth, and perhaps suboptimal intrauterine growth and CP. Migraine is common in women of reproductive age and is associated with risk of pre-eclampsia and maternal pregnancy-related and later stroke. The relationship of migraine or its treatment with adverse outcome in and beyond pregnancy warrants further study.
